FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4611000001103: Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1866441000001110 Magnesium trisilicate compound tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1984691000001116 Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Is a Compound magnesium trisilicate 250 mg tablet false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has excipient Lactose false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has active ingredient Aluminium false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has active ingredient Magnesium false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has active ingredient Trace element supplementation false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has active ingredient Magnesium trisilicate true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has active ingredient Aluminium hydroxide dried false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has active ingredient Magnesium trisilicate false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has specific active ingredient Magnesium trisilicate false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has specific active ingredient Aluminium hydroxide dried false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Is a Magnesium trisilicate compound tablets false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has specific active ingredient Aluminium hydroxide dried true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Has specific active ingredient Magnesium trisilicate true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Is a Magnesium trisilicate compound tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) 100 tablet (product) Is pack of False Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) 100 tablet (product) Has AMP True Magnesium trisilicate compound tablets (Kent Pharma (UK) Limited) (product) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start